{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:40:05Z","timestamp":1792608005897,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Thymoma-associated multiorgan autoimmunity (TAMA) is a rare paraneoplastic syndrome characterized by graft-versus-host disease (GVHD)\u2013like manifestations. The disorder is thought to arise from a disruption to central immune tolerance of T cells secondary to neoplastic growth of thymic epithelial cells. Thymic epithelial cells are crucial in T-cell education: distinguishing between self-antigens and foreign antigens. This process relies on a protein, the autoimmune regulator (AIRE), which negatively selects and eliminates T cells that are self-reactive. With neoplastic transformation of thymic cells, these cells may exhibit reduced AIRE, leading to an overabundance of autoreactive T cells. These autoreactive T cells mediate the sequelae of the GVHD-like presentation, with skin, liver, and gastrointestinal tract manifestations. We describe a case of a 74-year-old patient with a medical history of thymoma and multiple autoimmune conditions, who presented for diffuse psoriasiform eruption of the trunk and back. Skin biopsy further revealed epidermal hyperplasia with interface change, extensive dyskeratosis, and numerous apoptotic keratinocytes within parakeratotic scale, including striking involvement of the follicular epithelium. Our patient developed hepatobiliary and cholestasis injury, with rising bilirubin, AST, and ALT levels. Despite therapeutic modifications, his cutaneous and systemic disease progressed, and he died approximately 1 month after the diagnosis of TAMA due to complications of small bowel obstruction. This case highlights the pressing need for heightened clinical suspicion and a multidisciplinary team approach when presented with a thymoma patient.<\/jats:p>","DOI":"10.1097\/dad.0000000000003458","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:00:26Z","timestamp":1791986426000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Classic Cutaneous Presentation of Thymoma-Associated Multiorgan Autoimmunity and Review of the Literature"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5934-8896","authenticated-orcid":false,"given":"Rebecca","family":"Fliorent","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gershman","sequence":"additional","affiliation":[{"name":"Touro College of Osteopathic Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Magro","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"R1-20261021","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2007.08.010","article-title":"Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity?","volume":"114","author":"Offerhaus","year":"2007","journal-title":"Immunol Lett"},{"key":"R2-20261021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaad.2007.02.027","article-title":"Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease","volume":"57","author":"Wadhera","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R3-20261021","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cup.12642","article-title":"Graft-versus-host disease-like erythroderma: a manifestation of thymoma-associated multiorgan autoimmunity","volume":"42","author":"Warren","year":"2015","journal-title":"J Cutan Pathol"},{"key":"R4-20261021","first-page":"818","article-title":"Cutaneous manifestations of thymoma-associated multi-organ autoimmunity: a fatal sign","volume":"96","author":"Muramatsu","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"R5-20261021","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/1346-8138.13777","article-title":"Thymoma-associated multi-organ autoimmunity: a case of graft-versus-host disease-like erythroderma complicated by good syndrome successfully treated by thymectomy","volume":"44","author":"Fukushima","year":"2017","journal-title":"J Dermatol"},{"key":"R6-20261021","doi-asserted-by":"crossref","first-page":"e229163","DOI":"10.1136\/bcr-2018-229163","article-title":"Thymoma-associated multiorgan autoimmunity","volume":"12","author":"Hung","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R7-20261021","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jdcr.2020.06.007","article-title":"Thymoma-associated multiorgan autoimmunity initially manifested by graft-versus-host disease-like erythroderma: case report and possible therapeutic role of antimalarial drugs","volume":"6","author":"Hile","year":"2020","journal-title":"JAAD Case Rep"},{"key":"R8-20261021","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1111\/ijd.15199","article-title":"Thymoma-associated multiorgan autoimmunity with prominent muco-cutaneous involvement: two cases and review of the literature","volume":"60","author":"Pons Benavent","year":"2021","journal-title":"Int J Dermatol"},{"key":"R9-20261021","doi-asserted-by":"crossref","first-page":"2050313x211055928","DOI":"10.1177\/2050313X211055928","article-title":"Thymoma-associated multiorgan autoimmunity with cutaneous only presentation: a case report","volume":"9","author":"Bendayan","year":"2021","journal-title":"SAGE Open Med Case Rep"},{"key":"R10-20261021","doi-asserted-by":"crossref","first-page":"e2022206","DOI":"10.5826\/dpc.1204a206","article-title":"Dermatologic manifestations of Thymoma-associated Multiorgan Autoimmunity (TAMA) syndrome: cutaneous signs of an immune dysregulation","volume":"12","author":"Rossiello","year":"2022","journal-title":"Dermatol Pract Concept"},{"key":"R11-20261021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/cup.14743","article-title":"Thymoma-Associated Multiorgan autoimmunity (TAMA) presenting as a graft versus host disease-like erythroderma","volume":"52","author":"Hewitt","year":"2025","journal-title":"J Cutan Pathol"},{"key":"R12-20261021","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/ijd.17460","article-title":"Erythroderma in the spectrum of thymoma-associated multiorgan autoimmunity (TAMA) syndrome: a case report of a patient with thymoma and myasthenia gravis","volume":"64","author":"Bianco","year":"2025","journal-title":"Int J Dermatol"},{"key":"R13-20261021","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jdcr.2021.08.033","article-title":"Thymoma-associated multiorgan autoimmunity treated with multimodal therapy including extracorporeal photopheresis","volume":"16","author":"Wheat","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R14-20261021","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/1346-8138.17519","article-title":"First reported case of thymoma-associated multiorgan autoimmunity induced by COVID-19","volume":"51","author":"Hyobu","year":"2024","journal-title":"J Dermatol"},{"key":"R15-20261021","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00000478-199502000-00011","article-title":"Graft-versus-host-like colitis associated with malignant thymoma","volume":"19","author":"Kornacki","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R16-20261021","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/003655200750023660","article-title":"Graft-versus-Host disease-like syndrome in malignant thymoma","volume":"35","author":"Wang","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"R17-20261021","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2249.2011.04472.x","article-title":"Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course","volume":"166","author":"Hanafusa","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R18-20261021","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/cgt.2017.13","article-title":"Correlations of TNF-\u03b1 gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis in a northern Chinese Han population","volume":"24","author":"Yang","year":"2017","journal-title":"Cancer Gene Ther"},{"key":"R19-20261021","doi-asserted-by":"crossref","first-page":"e206227","DOI":"10.1172\/JCI206227","article-title":"Immune responses in aging adults","volume":"136","author":"Weyand","year":"2026","journal-title":"J Clin Invest"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:00:15Z","timestamp":1792605615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003458","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]}}}